This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Gabriele Dorn: Innovator in Neurological Treatments
Introduction
Gabriele Dorn is a notable inventor based in Rotkreuz, Switzerland. He has made significant contributions to the field of medical science, particularly in the treatment of neurological disorders. With a total of 2 patents, his work focuses on innovative methods that leverage the power of double-stranded RNA.
Latest Patents
Dorn's latest patents include groundbreaking methods for treating neurological disorders through the administration of double-stranded RNA (dsRNA). The first patent details a method involving intrathecal injection of an effective amount of dsRNA into a subject in need. This innovative approach aims to inhibit the expression of a target gene, providing a new avenue for treatment. The second patent reiterates this method, emphasizing the potential of pharmaceutical compositions that utilize dsRNA for effective treatment of neurological conditions.
Career Highlights
Gabriele Dorn is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore and develop advanced therapeutic strategies that address complex neurological disorders. His dedication to research and innovation has positioned him as a key figure in the medical community.
Collaborations
Dorn collaborates with esteemed colleagues such as Pamposh Ganju and Jonathan Hall. Their combined expertise fosters a dynamic research environment that enhances the development of novel treatments.
Conclusion
Gabriele Dorn's contributions to the field of neurological treatment through his innovative patents highlight his role as a leading inventor. His work continues to pave the way for advancements in medical science, offering hope for those affected by neurological disorders.